Sign in

CIK 0001559053

  • Accelerated filer

PROTHENA CORP PUBLIC LTD CO

Sign in to watch
Ticker
PRTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Ireland
Entity type
Operating
Phone
+353 12362500
Business address
77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
Former names
Prothena Corp plc, Neotope Corp Ltd
Open-market buys, last 90 days
$9,848,721
in 10 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. SCULLY WILLIAM P +$9.8M 10% owner 10 filings

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-02-23 Malecek Michael J Chief Legal Officer Grant or award · Stock Option (Right to Buy) +85,000 85,000
2022-01-12 EcoR1 Capital, LLC 10% owner Purchase +300,000 $37.50 $11.3M 11,584,280
2022-01-03 Selkoe Dennis J. Director Option exercise +5,000 $9.23 $46K 7,845
2022-01-03 Selkoe Dennis J. Director Sale −2,133 $46.81 $100K 5,712
2022-01-03 Selkoe Dennis J. Director Sale −2,375 $47.60 $113K 3,337
2022-01-03 Selkoe Dennis J. Director Sale −492 $49.48 $24K 2,845
2022-01-03 Selkoe Dennis J. Director Option exercise · Stock Option (Right to Buy) +5,000 6,000
2021-11-23 Walker Karin L Chief Accounting Officer Option exercise +4,519 $15.04 $68K 4,519
2021-11-23 Walker Karin L Chief Accounting Officer Sale −2,700 $57.51 $155K 1,819
2021-11-23 Walker Karin L Chief Accounting Officer Sale −1,819 $58.43 $106K 0
2021-11-23 Walker Karin L Chief Accounting Officer Option exercise · Stock Option (right to buy) −4,519 85,481
2021-11-19 Malecek Michael J See Remarks Option exercise +10,000 $10.27 $103K 10,000
2021-11-19 Malecek Michael J See Remarks Sale −10,000 $55.00 $550K 0
2021-11-19 Malecek Michael J See Remarks Option exercise · Stock Option (Right to Buy) −10,000 230,000
2021-11-01 Karp Carol D. Chief Regulatory Officer Option exercise +10,000 $15.04 $150K 10,000
2021-11-01 Karp Carol D. Chief Regulatory Officer Sale −2,338 $55.00 $129K 7,662
2021-11-01 Karp Carol D. Chief Regulatory Officer Sale −2,725 $56.65 $154K 4,937
2021-11-01 Karp Carol D. Chief Regulatory Officer Sale −4,937 $58.51 $289K 0
2021-11-01 Karp Carol D. Chief Regulatory Officer Option exercise · Stock Option (Right to Buy) −10,000 120,000
2021-10-27 Malecek Michael J See Remarks Option exercise +10,000 $10.27 $103K 10,000

Page 29 of 41 · 819 trades